With 386 Rare Diseases related patents published between 2002 and 2022, Pfizer Inc holds the most number of Rare Diseases patents in Croatia.
The second largest number of Rare Diseases related patents were published by Sanofi with 338 patents, of which 29.0% was contributed by its subsidiary Aventis Pharma SA. The third largest number of Rare Diseases related patents were published by F. Hoffmann-La Roche Ltd with 315 patents. The fourth largest number of Rare Diseases related patents were published by Johnson & Johnson with 257 patents, of which 53.3% was contributed by Janssen Pharmaceutica NV. The fifth largest number of Rare Diseases related patents were published by C. H. Boehringer Sohn AG & Co KG with 209 patents, of which 94.7% was contributed by its subsidiary Boehringer Ingelheim International GmbH.
The top five patent holders, i.e., Pfizer Inc, Sanofi, F. Hoffmann-La Roche Ltd, Johnson & Johnson, and C. H. Boehringer Sohn AG & Co KG, together held 1,505 Rare Diseases patents during the period.
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer